Giá của Medigene AG là bao nhiêu (MDG1)

Giá của Medigene AG (MDG1) là $0.14942078

Mũ thị trường của Medigene AG là gì (MDG1)

Giới hạn thị trường của Medigene AG (MDG1) là $3.86M

Medigene AG (MDG1) Chia Tách Cổ Phiếu

Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.

Năm	Chia tách	Tỷ lệ	Tỷ lệ cộng dồn
2024-08-29	1:2	x0.5	x0.125
2013-09-03	1:4	x0.25	x0.25

Năm

Chia tách

Tỷ lệ

Tỷ lệ cộng dồn

2024-08-29

1:2

x0.5

x0.125

2013-09-03

1:4

x0.25

Công ty	Số lần chia tách cổ phiếu	Tỷ lệ cộng dồn	Quốc gia
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Argenx SE ARGX.US	0	-	NL
Lonza Group AG LONN.SW	0	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	0	-	KR
UCB S.A. UCB.BR	0	-	BE

Công ty

Số lần chia tách cổ phiếu

Tỷ lệ cộng dồn

Quốc gia